Perforating Necrobiosis Lipoidica: Good Response to Adalimumab

Overview

Journal An Bras Dermatol

Specialty Dermatology

Date 2019 Dec 3

PMID 31789246

Citations 3

Authors

Alexandra Brugnera Nunes de Mattos

Carolina Finardi Brummer

Gabriela Di Giunta Funchal

Daniel Holthausen Nunes

Affiliations

Soon will be listed here.

Citing Articles

Ulcerative Necrobiosis Lipoidica Involving Atypical Site Over Upper Limb.

Sinha P, Raj C, Prashantha G, Madakshira M Indian J Dermatol. 2024; 69(6):487.

PMID: 39678741 PMC: 11642459. DOI: 10.4103/ijd.ijd_309_24.

Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis.

Hwang E, Abdelghaffar M, Shields B, Damsky W JID Innov. 2023; 3(5):100220.

PMID: 37719661 PMC: 10500476. DOI: 10.1016/j.xjidi.2023.100220.

Perforating Gout: Expanding the Differential for Transepidermal Elimination.

Bohdanowicz M, Bradshaw S Dermatopathology (Basel). 2023; 10(3):207-218.

PMID: 37489453 PMC: 10366899. DOI: 10.3390/dermatopathology10030029.

References

Hammami H, Youssef S, Jaber K, Dhaoui M, Doss N . Perforating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: a new case reported. Dermatol Online J. 2008; 14(7):11. View

Leister L, Korber A, Dissemond J . [Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab]. Hautarzt. 2013; 64(7):509-11. DOI: 10.1007/s00105-013-2535-z. View

Chung C, Rosengrant A, Helm K, Shupp D . Necrobiosis lipoidica occurring in a patient with rheumatoid arthritis on concurrent tumor necrosis factor-α inhibitor therapy. Int J Dermatol. 2014; 54(11):1294-6. DOI: 10.1111/ijd.12309. View

Peckruhn M, Tittelbach J, Elsner P . Update: Treatment of necrobiosis lipoidica. J Dtsch Dermatol Ges. 2017; 15(2):151-157. DOI: 10.1111/ddg.13186. View

Zhang K, Quan L, Hsu S . Treatment of necrobiosis lipoidica with etanercept and adalimumab. Dermatol Online J. 2009; 15(12):12. View